pan-influenza virus vaccines (adenoviral vector) (GenPhar)

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug Namepan-influenza virus vaccines (adenoviral vector) (GenPhar)
Drug Alias NamecAdVax-H1H2H7HxcAdVax-H1N1H5c1,3cAdVax-H5N1M1cAdVax-NA,MAcAdVax-H5N1M1 +[6] 
ClassificationVaccines > Application > Prophylactic vaccineVaccines > Development/production technology > Recombinant vector vaccine
Mechanisms of ActionImmunomodulators
TargetsNot applicable
Therapy Area/IndicationsInfluenza, Human
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesGenphar
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesGenphar
Active IndicationsN/A
Inactive IndicationsInfluenza, Human

Other Information

ATC CodeN/A
Related LinksN/A